Emily Conley

Emily Conley

Director/Board Member chez NUVALENT, INC.

Fortune : 601 $ au 31/03/2024

42 ans
Technology Services
Health Technology
Consumer Services

Profil

Emily Drabant Conley is currently the Chief Executive Officer & Director at Federation Bio, Inc. and the Chief Executive Officer at Renaissance Bio.
She is also a Director at Medrio, Inc., TMRW Life Sciences, Inc., and Nuvalent, Inc. Previously, she held positions as a Director at Start Somewhere LLC, the Ucsf Alliance Health Project, and 23andMe, Inc. Dr. Conley completed her undergraduate degree at Vanderbilt University and her doctorate at Stanford University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/04/2024 8 ( 0,00% ) 601 $ 31/03/2024

Postes actifs de Emily Conley

SociétésPosteDébut
NUVALENT, INC. Director/Board Member 02/02/2022
Director/Board Member 10/09/2019
Director/Board Member -
Chief Executive Officer 06/10/2020
Tous les postes actifs de Emily Conley

Anciens postes connus de Emily Conley

SociétésPosteFin
Ucsf Alliance Health Project Director/Board Member -
Corporate Officer/Principal -
Director/Board Member -
Voir l'expérience en détail de Emily Conley

Formation de Emily Conley

Vanderbilt University Undergraduate Degree
Stanford University School of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Emily Conley

Relations

42

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
NUVALENT, INC.

Health Technology

Entreprise privées6

Technology Services

Health Technology

Health Technology

Technology Services

Technology Services

Ucsf Alliance Health Project

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Emily Conley